May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Intra-operative Use of Mitomycin-C in Ocular Surface Epithelial Neoplasia Excision Prevents Recurrence. Histological Evidence and Long-term Follow-up
Author Affiliations & Notes
  • C.S. Siganos
    Ophthalmology, Heraklion University Hospital, Heraklion, Crete, Greece
  • E.V. Christodoulakis
    Ophthalmology, Heraklion University Hospital, Heraklion, Crete, Greece
  • V.P. Kozobolis
    Ophthalmology, University of Thrace, Alexandroupolis, Greece
  • A.N. Khoury
    Ophthalmology, University of Thrace, Alexandroupolis, Greece
  • Footnotes
    Commercial Relationships  C.S. Siganos, None; E.V. Christodoulakis, None; V.P. Kozobolis, None; A.N. Khoury, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 3722. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C.S. Siganos, E.V. Christodoulakis, V.P. Kozobolis, A.N. Khoury; Intra-operative Use of Mitomycin-C in Ocular Surface Epithelial Neoplasia Excision Prevents Recurrence. Histological Evidence and Long-term Follow-up . Invest. Ophthalmol. Vis. Sci. 2003;44(13):3722.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:To present histological evidence on the efficacy of intraoperative Mitomycin-C use in excision of ocular surface epithelial neoplasia for recurrence prevention. Methods: Eight patients (9 eyes), 4 males and 4 females, 56 to 87 years old, with conjunctival neoplasia, were operated during the period between October 1998 and May 2002. Excision of the lesion was combined with intra-operative application of Mitomycin-C 0.02% for 5 minutes. In 5 out of 9 cases, secondary biopsy was performed at least 28 months after surgery, from the area where the lesions were excised. Results: The follow-up period after excision ranged from 6 to 43 months (mean: 30.4 months). Histopathology revealed 4 cases with squamous cell carcinoma (SCC), one with carcinoma in situ, 3 with dysplasia and one case with actinic keratosis. Out of the 9 eyes, only one eye with SCC showed mild clinical recurrence that was successfully treated with one course of topical Mitomycin-C. Up to the last follow-up of this case (36 months), the lesion did not recur. The histological evidence of secondary biopsy performed in 5 eyes at a mean of 32.4 months after excision showed no recurrence. Conclusions: Clinical and histological evidence indicates that intraoperative use of Mitomycin-C in ocular surface epithelial neoplasia excision is a promising approach for recurrence prevention. More cases are needed to establish the efficacy of such an approach.  

Keywords: conjunctiva • cornea: clinical science • tumors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×